Diagnosis of GIST needs the identification of activating mutations in KIT or PDGFRA (molecular alterations) and expression of CD117 and/or CD34 (immunohistochemistry); while GI‐LMS express smooth muscle actin and desmin. This evidence concerns the gene DES and gastrointestinal stromal tumor.